Search Results - "Hoffmann, Thomas K"

Refine Results
  1. 1

    Clinical Significance of PD-L1 + Exosomes in Plasma of Head and Neck Cancer Patients by Theodoraki, Marie-Nicole, Yerneni, Saigopalakrishna S, Hoffmann, Thomas K, Gooding, William E, Whiteside, Theresa L

    Published in Clinical cancer research (15-02-2018)
    “…The microenvironment of head and neck squamous cell carcinomas (HNSCC) is highly immunosuppressive. HNSCCs expressing elevated levels of PD-L1 have especially…”
    Get full text
    Journal Article
  2. 2

    Total Laryngectomy-Still Cutting-Edge? by Hoffmann, Thomas K

    Published in Cancers (19-03-2021)
    “…Surgical removal of the larynx (total laryngectomy) offers a curative approach to patients with advanced laryngeal and hypopharyngeal (squamous cell) cancer…”
    Get full text
    Journal Article
  3. 3

    A Randomized Trial of Icatibant in ACE-Inhibitor–Induced Angioedema by Baş, Murat, Greve, Jens, Stelter, Klaus, Havel, Miriam, Strassen, Ulrich, Rotter, Nicole, Veit, Johannes, Schossow, Beate, Hapfelmeier, Alexander, Kehl, Victoria, Kojda, Georg, Hoffmann, Thomas K

    Published in The New England journal of medicine (29-01-2015)
    “…Thirty patients with ACE-inhibitor–induced angioedema were assigned to receive icatibant or standard therapy with intravenous prednisolone plus clemastine. The…”
    Get full text
    Journal Article
  4. 4

    Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma by Chen, Chao, Wei, Yan, Hummel, Michael, Hoffmann, Thomas K, Gross, Manfred, Kaufmann, Andreas M, Albers, Andreas E

    Published in PloS one (27-01-2011)
    “…Initiation, growth, recurrence, and metastasis of head and neck squamous cell carcinomas (HNSCC) have been related to the behavior of cancer stem cells (CSC)…”
    Get full text
    Journal Article
  5. 5

    The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer by Hofmann, Linda, Ludwig, Sonja, Vahl, Julius M, Brunner, Cornelia, Hoffmann, Thomas K, Theodoraki, Marie-Nicole

    “…Exosomes, the smallest group of extracellular vesicles, carry proteins, miRNA, mRNA, DNA, and lipids, which they efficiently deliver to recipient cells,…”
    Get full text
    Journal Article
  6. 6

    Angioedema in the emergency department: a practical guide to differential diagnosis and management by Bernstein, Jonathan A., Cremonesi, Paolo, Hoffmann, Thomas K., Hollingsworth, John

    “…Background Angioedema is a common presentation in the emergency department (ED). Airway angioedema can be fatal; therefore, prompt diagnosis and correct…”
    Get full text
    Journal Article Book Review
  7. 7

    NF-κB and Its Role in Checkpoint Control by Betzler, Annika C, Theodoraki, Marie-Nicole, Schuler, Patrick J, Döscher, Johannes, Laban, Simon, Hoffmann, Thomas K, Brunner, Cornelia

    “…Nuclear factor-κB (NF-κB) has been described as one of the most important molecules linking inflammation to cancer. More recently, it has become clear that…”
    Get full text
    Journal Article
  8. 8

    A clinical evaluation of patients with known mutations (plasminogen and factor XII) with a focus on prophylactic treatment by Lochbaum, Robin, Trainotti, Susanne, Hoffmann, Thomas K, Greve, Jens, Hahn, Janina

    Published in The Journal of dermatological treatment (01-12-2024)
    “…Hereditary angioedema with normal C1-inhibitor (HAE-nC1-INH) is a rare genetic disease. The symptoms can resemble other forms of hereditary angioedema (HAE),…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Therapeutic Efficacy of Icatibant in Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Case Series by Bas, Murat, MD, Greve, Jens, MD, Stelter, Klaus, MD, Bier, Henning, MD, Stark, Thomas, MD, Hoffmann, Thomas K., MD, Kojda, Georg, PharmD, PhD

    Published in Annals of emergency medicine (01-09-2010)
    “…Study objective The pathophysiology of angiotensin-converting enzyme inhibitor (ACEi)–induced angioedema most likely resembles that of hereditary angioedema,…”
    Get full text
    Journal Article
  11. 11

    CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity by Theodoraki, Marie-Nicole, Matsumoto, Akihiro, Beccard, Inga, Hoffmann, Thomas K., Whiteside, Theresa L.

    Published in Oncoimmunology (01-01-2020)
    “…The molecular cargo of tumor-cell-derived exosomes (TEX) mimics that of parental tumor cells. Thus, TEX could potentially serve as noninvasive biomarkers of…”
    Get full text
    Journal Article
  12. 12

    The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer by Hofmann, Linda, Ludwig, Sonja, Schuler, Patrick J, Hoffmann, Thomas K, Brunner, Cornelia, Theodoraki, Marie-Nicole

    “…Head and neck squamous cell carcinomas (HNSCC) are highly immune suppressive and aggressive malignancies. As part of the tumor microenvironment, exosomes…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Thrombosis of the internal jugular vein in the ENT-department — Prevalence, causes and therapy: A retrospective analysis by Hahn, Janina, Nordmann-Kleiner, Melanie, Hoffmann, Thomas K., Greve, Jens

    Published in Auris, nasus, larynx (01-08-2019)
    “…Less than 5% of deep vein thrombosis is due to thrombosis of the internal jugular vein. Genetic, malignant or inflammatory underlying diseases as well as…”
    Get full text
    Journal Article
  17. 17
  18. 18

    T Cell Specific BOB.1/OBF.1 Expression Promotes Germinal Center Response and T Helper Cell Differentiation by Betzler, Annika C, Ezić, Jasmin, Abou Kors, Tsima, Hoffmann, Thomas K, Wirth, Thomas, Brunner, Cornelia

    Published in Frontiers in immunology (04-05-2022)
    “…The transcriptional co-activator BOB.1/OBF.1 is expressed in both B and T cells. The main characteristic of conventional BOB.1/OBF.1 deficient mice is the…”
    Get full text
    Journal Article
  19. 19

    Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy by Puntigam, Lisa K, Jeske, Sandra S, Götz, Marlies, Greiner, Jochen, Laban, Simon, Theodoraki, Marie-Nicole, Doescher, Johannes, Weissinger, Stephanie E, Brunner, Cornelia, Hoffmann, Thomas K, Schuler, Patrick J

    “…Endogenous control mechanisms, including immune checkpoints and immunosuppressive cells, are exploited in the process of tumorigenesis to weaken the anti-tumor…”
    Get full text
    Journal Article
  20. 20